⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29046395 | 1.00 | — | — | |
| SCHEMBL14237212 | 1.00 | — | — | |
| SCHEMBL29849998 | 0.85 | CYP1A2 (0.55) | — | |
| SCHEMBL28360407 | 0.78 | CYP1A2 (0.46) | — | |
| SCHEMBL2480098 | 0.78 | — | — | |
| SCHEMBL28339700 | 0.78 | — | — | |
| SCHEMBL28360408 | 0.78 | CYP1A2 (0.46) | — | |
| SCHEMBL3505755 | 0.78 | — | — | |
| SCHEMBL19925598 | 0.76 | — | — | |
| SCHEMBL10621800 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121045168-A | Rivaroxaban intermediate Process for the preparation of intermediates | 山东新时代药业有限公司 | 2025-12-02 | — | — | CN | disclosed |
| CN-116375592-A | Novel long-acting low-toxicity cationic lipid compounds and compositions thereof | 北京悦康科创医药科技股份有限公司 | 2023-07-04 | — | — | CN | disclosed |
| EP-2254887-B9 | OXAZOLIDINONE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2013-05-29 | — | — | EP | disclosed |
| EP-2254887-B1 | OXAZOLIDINONE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2012-12-19 | — | — | EP | disclosed |